The vast majority of uterine leiomyomas (UL) either display clonal karyotype aberrations detected by classical cytogenetics or mutations of Mediator Subcomplex 12 (MED12) [1,2], or both. This evidence concerns the gene MED12 and Uterine leiomyoma.